Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
European Journal of Gastroenterology & Hepatology|December 2, 2016
Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapySudeep Tanwar, Paul M Trembling, Brian J Hogan, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 25, 2021
Sequential assessment of bowel function and anorectal physiology after anterior resection for cancer: a prospective cohort studySophie A Pilkington, Rahul Bhome, Sally Gilbert, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2022
A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variantGregory S Sawicki, Mark Chilvers, John McNamara, et al.
European Heart Journal|June 3, 2017
Remote management of heart failure using implantable electronic devicesJohn M Morgan, Sue Kitt, Jas Gill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2011
18F-FDG uptake rate is a biomarker of eosinophilic inflammation and airway response in asthmaR Scott Harris, José G Venegas, Chanikarn Wongviriyawong, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2021
Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory FailureJehan Alladina, Sean D Levy, Josalyn L Cho, et al.
American Journal of Respiratory Cell and Molecular Biology|June 24, 2021
Smoking and Human Immunodeficiency Virus 1 Infection Promote Retention of CD8<sup>+</sup> T Cells in the Airway MucosaBjörn Corleis, Josalyn L Cho, Samantha J Gates, et al.
Pageof 20